[Enterosorption in ulcerative lesions of the gastrointestinal tract with concomitant intestinal dysbacteriosis].
Adjuvant use of enterosorbents in combined therapy of gastroduodenal ulcers (158 patients), nonspecific ulcerative colitis with intestinal dysbacteriosis was assessed. Enterosorption in combined therapy of gastrointestinal diseases with dysbacteriosis potentiated positive effect. The highest benefit of enterosorption occurs in intestinal affections (nonspecific ulcerative colitis, irritable bowel-syndrome, chronic enteritis, colitis). In gastroduodenal ulcer lignin sorbent (polyfepan) is preferable. Polyfepan acted positively on intestinal dysbacteriosis through eliminating Escherichia with hemolyzing properties and enterococci, by reducing lack of bifidobacteria.
Krylov
A A
AA
Beliakov
N A
NA
Sapego
A V
AV
Stolov
S V
SV
D000328:Adult; D004381:Duodenal Ulcer / Q000382:microbiology / Q000628:therapy*; D004756:Enterobacteriaceae Infections / Q000382:microbiology / Q000628:therapy*; D016061:Enterosorption; D005069:Evaluation Studies as Topic; D016481:Helicobacter Infections / Q000382:microbiology / Q000628:therapy; D016480:Helicobacter pylori; D006801:Humans; D007410:Intestinal Diseases / Q000382:microbiology / Q000628:therapy*; D008031:Lignin / Q000627:therapeutic use; D008297:Male; D013276:Stomach Ulcer / Q000382:microbiology / Q000628:therapy*
C056995:polyfepan; D008031:Lignin
Enterosorbtsiia pri iazvennykh porazheniiakh zheludochno-kishechnogo trakta s soputstvuiushchim disbakteriozom kishechnika.